VKTX: Viking Therapeutics Inc

VKTX新闻

• 13:20 How Will Novo's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
• 12:06 The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics
• 15:33 Canaccord Genuity Maintains Buy on Viking Therapeutics, Lowers Price Target to $106
• 13:30 4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now
• 12:15 Can Viking Therapeutics Carve Out a Place in the Obesity Market?
• 13:15 How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q3 Results?
• 20:45 Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know
• 21:05 UBS Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $94
• 15:52 Viking Therapeutics Starts Phase III Development of Obesity Pill
• 12:30 Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?
• 11:09 维京治疗公司启动 SUNRISE 三期临床项目，评估口服 VK2735——一种 GLP-1 和葡萄糖依赖性胰岛素促泌多肽受体双重激动剂
• 11:09 Viking Therapeutics Initiates SUNRISE Phase 3 Clinical Program For Oral VK2735 Dual Agonist Of GLP-1 And Glucose-Dependent Insulinotropic Polypeptide Receptors
• 17:35 10 Health Care Stocks With Whale Alerts In Today’s Session
• 17:35 今日交易中有鲸鱼警报的10只医疗保健股票
• 15:24 Novo Down 11% in a Month: How Should Investors Approach the Stock Now?
• 20:45 Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider
• 20:50 Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know
• 11:31 LLY Stock Down 2% in 3 Months: Is the Dip a Buying Opportunity?
• 08:16 火币HTX已上线AKAM、VKTX、H100、FOXA、INTU、CT永续合约
• 08:16 HTX Lists AKAM, VKTX, H100, FOXA, INTU, CT Perpetual Contracts
• 17:14 Truist Securities维持对Viking Therapeutics的“买入”评级，将目标价下调至85美元
• 17:14 Truist Securities Maintains Buy on Viking Therapeutics, Lowers Price Target to $85
• 15:17 VKTX Advances Obesity Program With New Oral Maintenance Study
• 14:29 INSM Stock Slides on CFO Exit, Reiterates '26 Sales View